Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
72.25
+0.18 (0.25%)
At close: Jan 6, 2026, 4:00 PM EST
72.02
-0.23 (-0.32%)
After-hours: Jan 6, 2026, 7:50 PM EST
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $10.89 billion as of January 6, 2026. Its market cap has increased by 178.69% in one year.
Market Cap
10.89B
Enterprise Value
9.06B
1-Year Change
178.69%
Ranking
Category
Stock Price
$72.25
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $10.89B, an increase of 980.53%. That is a compound annual growth rate of 53.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 10.86B | -0.08% |
| Dec 31, 2025 | 10.87B | 213.25% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |